Shares of Godavari Biorefineries Ltd (GBL), one of India’s leading ethanol producers, were in strong demand on Friday, July 4, 2025, hitting the 5% upper circuit at ₹258.60 per share.
The rally followed the company’s announcement on Thursday (July 3) that it had secured a European patent for a novel anticancer molecule, marking a significant milestone in its healthcare innovation efforts.
In a filing with the exchange, GBL stated, “The Company has been granted a patent in Europe for our novel anticancer molecule This patent is now validated in Spain, the UK, and as a Unitary Patent.”
The patent subject area is “Anti-Cancer Research Segment”. The patent cover very potent anticancer compound with proven efficacy on cancer and cancer stem cell.
In terms of cancer biology, company’s research and development activities are aimed at creating value as well as optimising current resources and processes.
